文献速递皮肤肿瘤

前哨淋巴结内痣不影响皮肤黑色素瘤患者生存

Intra-nodal nevi in sentinel node-negative patients with cutaneous melanoma does not influence survival.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-10-17

INN在SLNB中患病率为5.0%,INN组总生存与SLNB阴性组无显著差异(全体患者中位随访5.7年),支持将INN患者按SLNB阴性处理。

要点

  • INN在SLNB中的患病率为5.0%,临床应按SLNB阴性管理。
  • INN组总生存与SLNB阴性组无显著差异,中位随访5.7年。
  • INN多见于躯干和上肢、较年轻患者,Breslow厚度中位数与SLNB阴性者相似。

核心结论

  • INN患者与SLNB阴性患者总生存无显著差异,INN诊断似乎可靠,现行按SLNB阴性处理的做法合适。

研究设计与样本

  • 从病理文本文件中提取临床与病理变量,采用Kaplan-Meier分析比较INN组、SLNB阴性组与SLNB阳性组间的差异。

主要发现

  • INN在SLNB中的患病率为5.0%。
  • INN组黑色素瘤的Breslow厚度中位数与SLNB阴性组相似,且更常见位于躯干和上肢、患者更年轻(与SLNB阴性和阳性组相比)。
  • INN组总生存与SLNB阴性组相比无显著差异(全体患者中位随访5.7年)。

关键数值与推荐

  • INN在SLNB中的患病率为5.0%。
  • 全体患者中位随访5.7年。
  • INN组与SLNB阴性组总生存无显著差异。

临床怎么用

  • 对SLNB中诊断为INN且无淋巴结黑色素瘤转移的患者,可按SLNB阴性患者管理。

局限性

  • 数据来自病理文本文件提取,摘要未报告INN误判为转移或转移误判为INN的具体比例。
  • 为登记库回顾性队列,摘要未报告多因素校正结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma patients with intra-nodal nevi (INN) and without melanoma metastasis in the sentinel lymph node biopsy (SLNB) are generally treated as patients with negative SLNB. However, diagnosis of INN may be difficult and nodal melanoma metastases may falsely be regarded as INN. OBJECTIVES: Our aim was to evaluate the clinical significance of INN in the SLNB in patients with primary cutaneous melanoma on a nationwide level in The Netherlands by comparing survival between three groups: patients with INN and without nodal melanoma metastasis (INN group), patients without INN and without nodal melanoma metastasis (negative SLNB group) and patients with nodal melanoma metastasis irrespective of INN (positive SLNB group). METHODS: Data were obtained from 'PALGA', the Dutch Nationwide Network and Registry of Histopathology and Cytopathology, yielding a cohort of adults with histologically proven, primary, invasive cutaneous melanoma patients in The Netherlands diagnosed between 2000 and 2014 who underwent SLNB. Clinical and pathological variables were extracted from the pathology text files. Differences between patients with INN, negative SLNB and positive SLNB were analysed using Kaplan-Meier analysis. RESULTS: A total of 11 274 patients were eligible for inclusion. The prevalence of INN in the SLNB was 5.0%. Melanomas with INN had similar median Breslow thickness compared to melanomas with negative SLNB and were more frequently located on trunk and upper limbs and observed in younger patients compared to melanomas with negative and positive SLNB. Overall survival of patients with INN showed no significant difference compared with negative SLNB (median follow-up of 5.7 years of all patients). CONCLUSIONS: As there seems to be no difference in overall survival between patients with INN and negative SLNB, the diagnosis of INN seems to be reliable. Current practice to treat patients with INN as patients with negative SLNB appears to be appropriate.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. de Beer FSA, van Diest PJ, Sigurdsson V, et al. Intra-nodal nevi in sentinel node-negative patients with cutaneous melanoma does not influence survival. J Eur Acad Dermatol Venereol. 2019. PMID: 31318994. doi:10.1111/jdv.15814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。